Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.1M
+60.5% from 2023
Prescriptions
45
$25,105.46 per claim
Patients
-
6 prescribers
Total spending, 2024
$1.1M
- per patient
Medicare prescription drug plans paid $1.1M for Tivdak in 2024, for 45 prescriptions and refills to - patients (up 60.5% from 2023). The average cost per claim was $25,105.46.
California had the highest Medicare cost for Tivdak in 2024: $470K for 17 claims, followed by Florida ($431K).
Eijean Wu, gynecological oncology in Los Angeles, CA, had the highest Medicare cost for Tivdak in 2024: 14 claims costing $377K.
Tivdak is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Seagen/Pfizer.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eijean Wu Los Angeles, CA | Gynecological Oncology | 14 | Under 11 | $377K |
| Manjesh Lingamurthy Sarasota, FL | Hematology-Oncology | 11 | Under 11 | $301K |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4 | 16 | - | $401K |
| 2023 | 6 | 26 | - | $704K |
| 2024 | 6 | 45 | - | $1.1M |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Manufacturer | Claims | Spending |
|---|---|---|
| Seagen/Pfizer PFE | 45 | $1.1M |